g0d4ather / Shutterstock.com
The US Food and Drug Administration (FDA) has released a final rule to reduce unnecessary litigation between brand owners and generic drugs producers.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FDA, ANDA, NDA, FDCA, Orange Book, patent, generics